Bharat Biotech's intranasal Covid vaccine Tuesday got emergency use approval from the Drugs Controller General of India (DCGI). This will be India's first nasal vaccine for COVID-19.
Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a 'Big boost' to India's fight against Covid-19.
He took to Twitter and said, "Big Boost to India's Fight Against COVID-19! Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation."
"This step will further strengthen our collective fight against the pandemic. India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji's leadership," he added.
READ | ‘Time for united Opposition’: Bihar CM Nitish Kumar breaks silence on being PM candidate in 2024 polls
.
